Results 11 to 20 of about 8,313 (261)

Toxic Epidermal Necrolysis and Recurrent Implantation Failure: Unveiling a Rare Phenomenon During Pregnancy. [PDF]

open access: yesClin Case Rep
ABSTRACT Hydroxychloroquine (HCQ) is a common treatment for recurrent implantation failure (RIF), which may be associated with diverse side effects. We report a case of a 36‐year‐old RIF3 pregnant female through in vitro fertilization (IVF) presented to the emergency department with painful, itchy, macular, erythematous, blanchable, and exfoliative ...
Ghasemi Tehrani H   +4 more
europepmc   +2 more sources

Current state of the problem of exfoliative dermatitis

open access: yesЛечащий Врач, 2021
The article presents data on exfoliative dermatitis, characterized by diffuse erythema and skin peeling, affecting more than 90% of the total body surface. The most common diseases, previous to exfoliative dermatitis, are psoriasis, atopic dermatitis and
L. A. Yusupova
doaj   +1 more source

Synopsis of the antimicrobial use guidelines for canine pyoderma by the International Society for Companion Animal Infectious Diseases (ISCAID). [PDF]

open access: yesVet Dermatol
Abstract Background Canine pyoderma is one of the most common presentations in small animal practice, frequently leading to antimicrobial prescribing. Objectives To provide clinicians with antimicrobial treatment guidelines for staphylococcal pyoderma, including those involving meticillin‐resistant staphylococci.
Loeffler A   +9 more
europepmc   +2 more sources

Severe dapsone hypersensitivity syndrome in a child [PDF]

open access: yesKorean Journal of Pediatrics, 2013
Dapsone (4,4'-diaminodiphenylsulfone, DDS), a potent anti-inflammatory agent, is widely used in the treatment of leprosy and several chronic inflammatory skin diseases.
So Yoon Choi   +4 more
doaj   +1 more source

Elranatamab for Relapsed/Refractory Multiple Myeloma With Severe Renal Impairment Requiring Hemodialysis. [PDF]

open access: yesHematol Oncol
ABSTRACT Relapsed/refractory multiple myeloma (RRMM) patients with dialysis‐dependent renal impairment face limited therapeutic options due to exclusion from clinical trials, a lack of evidence‐based guidelines, and inferior outcomes. Bispecific antibodies targeting B‐cell maturation antigen (BCMA) have shown promise in RRMM treatment but remain ...
Hoffmann M   +7 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy